Synthesis, Cruzain Docking, and in vitro Studies of Aryl-4-Oxothiazolylhydrazones Against Trypanosoma cruzi
✍ Scribed by Ana Cristina Lima Leite; Diogo Rodrigo de M. Moreira; Marcos V. de O. Cardoso; Marcelo Zaldini Hernandes; Valéria R. Alves Pereira; Ricardo O. Silva; Alice C. Kiperstok; Milena da S. Lima; Milena B. P. Soares
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 273 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1860-7179
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Research in recent years has demonstrated that the Trypanosoma cruzi cysteine protease cruzain (TCC) is a valid chemotherapeutic target. Herein we describe a small library of aryl‐4‐oxothiazolylhydrazones that have been tested in assays against T. cruzi cell cultures. The docking studies carried out suggest that these compounds are potential ligands for the TCC enzyme. The most promising compound of this series, N‐(4‐oxo‐5‐ethyl‐2′‐thiazolin‐2‐yl)‐N′‐phenylthio‐(Z)‐ethylidenehydrazone (6 f), was shown to be very active at non‐cytotoxic concentrations in in vitro assays with mammalian cells and has a potency comparable with reference drugs such as nifurtimox (Nfx) and benznidazole (Bdz).
📜 SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v